IGHE and asthma: Asthma is an eosinophilic/Th2 disorder, and novel therapeutics targeting Th2 cytokines (IL-4, IL-5 and IL-13) and IgE have achieved excellent improvements in disease control, although these therapeutics are applicable to only a sub group of patients in clinical studies [5, 37].